Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals
US-2026085057-A1 · Mar 26, 2026 · US
Bayer Pharma AG patents
Bayer Pharma AG holds 878 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 878 |
| Recent patents | 84 |
| First publication | Jan 1, 2015 |
| Latest publication | Mar 26, 2026 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
US-12559473-B2 · Feb 24, 2026 · US
Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid esters
US-2026015355-A1 · Jan 15, 2026 · US
MASP inhibitory compounds and uses thereof
US-12503491-B2 · Dec 23, 2025 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
US-12486248-B2 · Dec 2, 2025 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Substituted indazoles useful for treatment and prevention of allergic and/or inflammatory diseases in animals
US-2026085057-A1 · Mar 26, 2026 · US
Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs
US-12559473-B2 · Feb 24, 2026 · US
Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carbox-amide by racemate separation by means of diastereomeric tartaric acid esters
US-2026015355-A1 · Jan 15, 2026 · US
MASP inhibitory compounds and uses thereof
US-12503491-B2 · Dec 23, 2025 · US
2,4,5-trisubstituted 1,2,4-triazolones useful as inhibitors of DHODH
US-12486248-B2 · Dec 2, 2025 · US
Top CPC classifications
Most common classification codes in this portfolio.
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 856 |
| Chemistry & Metallurgy | 765 |
| Physics | 35 |
| Cross-Sectional Technologies | 23 |
| Operations & Transport | 11 |
| Mechanical Engineering | 2 |
| Electricity | 1 |
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- How many patents does Bayer Pharma AG have in patentsdb?
- Bayer Pharma AG is linked to 878 publications as assignee in our database.
- What technology areas does Bayer Pharma AG patent most?
- Top mapped technology areas by patent count: Human Necessities (856); Chemistry & Metallurgy (765); Physics (35).
- Is Bayer Pharma AG's patent activity growing?
- In our data, assignee counts were 34 in 2024 and 23 in 2025 (lower year over year).
- What are recent patents assigned to Bayer Pharma AG?
- See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.